ReviewTherapeutic advances in gastroenterology2015

Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma.

Hugo Ford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.